Skip to main content
Midas Edge

Guardant Health, Inc.

For the period ended Sep 30, 2025. Filed Oct 29, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Oct 29, 2025

GH$155.35-2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) (unaudited)

(in thousands, except share data)

Three Months Ended September 30, 2025
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Deficit
Shares · Amount · Treasury Stock
Balance as of July 1, 2025124,477,904$1$(45,010)$2,516,550$(3,723)$(2,773,293)$(305,475)
Issuance of common stock upon exercise of stock options117,508——3,721——3,721
Vesting of restricted stock units410,303——————
Employee taxes paid related to net share settlement of restricted stock units———(2,265)——(2,265)
Stock-based compensation———42,808——42,808
Other comprehensive loss————(537)—(537)
Net loss—————(92,725)(92,725)
Balance as of September 30, 2025125,005,715$1$(45,010)$2,560,814$(4,260)$(2,866,018)$(354,473)
Three Months Ended September 30, 2024
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Deficit
Shares · Amount
Balance as of July 1, 2024122,969,580$1$2,363,501$(5,640)$(2,359,475)$(1,613)
Issuance of common stock upon exercise of stock options4,143—20——20
Vesting of restricted stock units184,695—————
Employee taxes paid related to net share settlement of restricted stock units——(2,874)——(2,874)
Stock-based compensation——49,769——49,769
Other comprehensive income———2,356—2,356
Net loss————(107,754)(107,754)
Balance as of September 30, 2024123,158,418$1$2,410,416$(3,284)$(2,467,229)$(60,096)
Nine Months Ended September 30, 2025
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Deficit
Shares · Amount · Treasury Stock
Balance as of January 1, 2025123,994,006$1$—$2,443,788$(5,201)$(2,578,235)$(139,647)
Issuance of common stock upon exercise of stock options220,541——6,046——6,046
Vesting of restricted stock units1,457,132——————
Common stock issued under employee stock purchase plan310,387——7,680——7,680
Employee taxes paid related to net share settlement of restricted stock units———(25,183)——(25,183)
Stock-based compensation———123,027——123,027
Repurchase of treasury stock(976,351)—(45,010)———(45,010)
Unwinding of convertible note hedges———5,456——5,456
Other comprehensive income————941—941
Net loss—————(287,783)(287,783)
Balance as of September 30, 2025125,005,715$1$(45,010)$2,560,814$(4,260)$(2,866,018)$(354,473)
Nine Months Ended September 30, 2024
Common Stock · Additional Paid-in Capital · Accumulated Other Comprehensive Loss · Accumulated Deficit · Total Stockholders’ Equity (Deficit)
Shares · Amount
Balance as of January 1, 2024121,629,861$1$2,304,220$(3,675)$(2,141,862)$158,684
Issuance of common stock upon exercise of stock options581,495—2,597——2,597
Vesting of restricted stock units575,236—————
Common stock issued under employee stock purchase plan371,826—7,212——7,212
Employee taxes paid related to net share settlement of restricted stock units——(7,658)——(7,658)
Stock-based compensation——104,045——104,045
Other comprehensive income———391—391
Net loss————(325,367)(325,367)
Balance as of September 30, 2024123,158,418$1$2,410,416$(3,284)$(2,467,229)$(60,096)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.